Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 12/20 | 0.62 |
| ▸ | MMP9 | P14780 | 11/20 | 0.62 |
| ▸ | MMP8 | P22894 | 11/20 | 0.62 |
| ▸ | MMP13 | P45452 | 8/20 | 0.62 |
| ▸ | MMP3 | P08254 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | IKBKB | O14920 | 1/20 | 0.44 |
| ▸ | PRCP | P42785 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3096830 | 0.91 | MMP2 (0.49) | MMP2MMP9MMP8MMP13MMP3 | |
| SCHEMBL11949004 | 0.89 | MMP2 (0.48) | MMP2MMP9MMP8MMP13MMP3 | |
| SCHEMBL3098570 | 0.83 | MMP2 (0.57) | MMP2MMP9MMP8MMP13KDM4E | |
| SCHEMBL3096806 | 0.83 | RAF1 (0.49) | MMP2MMP9MMP8MMP13MMP3 | |
| SCHEMBL3099855 | 0.82 | CYP2D6 (0.48) | MMP2MMP9MMP8MMP13MMP3 | |
| SCHEMBL11949014 | 0.81 | EGFR (0.53) | MMP2MMP9MMP8MMP13MMP3 | |
| SCHEMBL11949031 | 0.80 | NR4A2 (0.48) | MMP2MMP9MMP8MMP13ADORA3 | |
| SCHEMBL11948994 | 0.80 | EGFR (0.52) | MMP2MMP9MMP8MMP13KDM4E | |
| SCHEMBL11957177 | 0.80 | MMP2 (0.51) | MMP2MMP9MMP8MMP13KDM4E | |
| SCHEMBL3104076 | 0.80 | MMP2 (0.59) | MMP2MMP9MMP8MMP13ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2154966-B1 | BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF | UNIV NEW YORK STATE RES FOUND (US) | 2013-08-21 | — | — | EP | disclosed |
| US-8232410-B2 | Benzimidazoles and pharmaceutical compositions thereof | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2012-07-31 | — | — | US | disclosed |
| US-20100256203-A1 | BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256203-A1 | BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF | TBCD, TBC1D5, CFTR | MMP2 4155/4885MMP9 4514/4885MMP8 1359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.